7th Annual Reglera Reproductive Compliance Conference Slated for September 19-20, in Arlington, Virginia

Share Article

Reglera, LLC’s 2013 Reproductive Regulatory Compliance Conference features interactive education sessions/discussions regarding the impact of FDA regulations.

Reglera, LLC recently announced its 7th Reproductive Regulatory Compliance Conference is slated to be held September 19-20, 2013 at the Crystal City Marriott with complimentary airport shuttle and direct Metro access to downtown Washington, DC.

New to the conference this year, The Reproductive Compliance Conference will feature interactive sessions with live audience polls to challenge attendees’ knowledge of the current tissue regulations. Focused group discussions will encourage and facilitate in-depth dialogue and networking among participants.

Specific presentation topics will include (but are not limited to) the following:
Demystifying Donor Requirements
Donor Testing Requirements
Trends in the Industry: Working with Donor Banks and Agencies
Establishing Procedures
Enforcement Activity including recent Orders to Cease Manufacturing and Warning Letters

Reglera Presenters are experts in the reproductive regulatory field including:
Clay Anselmo, RAC, President
Martha Wells, MPH, RAC-VP of Regulatory Affairs for Tissue and Biologics
Rich Weiskopf, RAC, Senior Quality Assurance Director
Amy Johnson, CTBS, Tissue Services Manager
Cindy Blinci, CTBS, CQA (ASQ), Tissue Specialist

To secure your attendance at the Reproductive Compliance Conference 2013, visit the registration page on Reglera’s website, http://www.reglera.com. Space is limited and reservations will be made on a first-come first-served basis. For questions regarding the conference, please email John Dupont at dupontjo(at)reglera(dot)com or call (303) 832-8200.

--------------------------------------------------------------------------------

About Reglera: Based in Wheat Ridge, Colorado, Reglera, a Dohmen Company, provides best practice compliance and quality assurance services to more than 500 hundred medical device and human cellular tissue companies. With one of the largest consulting staffs in the industry including hundreds of experts in device and tissue located in the US and Israel, Reglera has helped both small start-ups and global corporations accelerate growth and profitability with comprehensive consulting and outsourcing services. For more information regarding Reglera services, visit http://www.reglera.com or contact Brian Tucker at 1.800.341.4255 or info(at)reglera(dot)com.

About Dohmen: Founded in 1858, Dohmen is a privately-held, Life Science Services Company, focused on creating a more efficient, affordable and accessible healthcare supply system. As the trusted partner to more than 600 Biopharma, Medtech and advanced therapy innovators, Dohmen propels start-up, mid-tier and Fortune 500 companies with support services that span the commercialization continuum from pre-approval regulatory consulting to in-home patient services. With a tradition of innovation that spans over 155 years, we’re driven by the desire to reduce cost and complexity within today’s healthcare system, using a progressive model that connects life science companies with the patients they serve.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carole Pfeil, SVP Marketing Communcations
Visit website

Media